Back

Clinical characteristics and genetic substrate of lone atrial fibrillation: a single center experience

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: basic science - epidemiology Genetic Causes EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Paolo Berruquier

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

8 More presentations in this session

Presentation thumbnail
A novel score predictor for atrial fibrillation in cardiac implantable electronic device patients
Doctor S. Jaroonpipatkul (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Postoperative atrial fibrillation is associated with late mortality independently of patient comorbidities: a systematic review and reconstructed individual patient data meta-analysis.
Mr M. Kawczynski (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Investigating the relationship between the leukocyte telomere length and the incidence of atrial fibrillation: a study utilizing data from the UK Biobank
Doctor H. Kim (Ulsan, KR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation is perpetuated by human heart secretome in ex-vivo langendorff-perfused hearts.
Associate Professor F. Hohendanner (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Doctor M. Klis (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: basic science - epidemiology

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Whole exome sequencing in young atrial fibrillation patients
thumbnail
Congress Presentation
Early-onset atrial fibrillation is a risk marker for cardiomyopathy: genetic insights from the UK Biobank
thumbnail
Congress Presentation
Polygenic risk score for prediction of atrial fibrillation according to presence of the hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources